Research ExplorerPublicationsQuality of life measurement in teledermatology. Position sta...

Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology

Standard

Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology. / Chernyshov, P V; Finlay, A Y; Tomas-Aragones, L; Tognetti, L; Moscarella, E; Pasquali, P; Manolache, L; Pustisek, N; Svensson, A; Marron, S E; Bewley, A; Salavastru, C; Suru, A; Koumaki, D; Linder, D; Abeni, D; Augustin, M; Blome, C; Salek, S S; Evers, A W M; Poot, F; Sampogna, F; Szepietowski, J С.

In: J EUR ACAD DERMATOL, Vol. 38, No. 2, 02.2024, p. 254-264.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Chernyshov, PV, Finlay, AY, Tomas-Aragones, L, Tognetti, L, Moscarella, E, Pasquali, P, Manolache, L, Pustisek, N, Svensson, A, Marron, SE, Bewley, A, Salavastru, C, Suru, A, Koumaki, D, Linder, D, Abeni, D, Augustin, M, Blome, C, Salek, SS, Evers, AWM, Poot, F, Sampogna, F & Szepietowski, JС 2024, 'Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology', J EUR ACAD DERMATOL, vol. 38, no. 2, pp. 254-264. https://doi.org/10.1111/jdv.19570

APA

Chernyshov, P. V., Finlay, A. Y., Tomas-Aragones, L., Tognetti, L., Moscarella, E., Pasquali, P., Manolache, L., Pustisek, N., Svensson, A., Marron, S. E., Bewley, A., Salavastru, C., Suru, A., Koumaki, D., Linder, D., Abeni, D., Augustin, M., Blome, C., Salek, S. S., ... Szepietowski, J. С. (2024). Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology. J EUR ACAD DERMATOL, 38(2), 254-264. https://doi.org/10.1111/jdv.19570

Vancouver

Chernyshov PV, Finlay AY, Tomas-Aragones L, Tognetti L, Moscarella E, Pasquali P et al. Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology. J EUR ACAD DERMATOL. 2024 Feb;38(2):254-264. https://doi.org/10.1111/jdv.19570

Bibtex

@article{091ccab10f7345b5b8b39ca4b6584ab7,
title = "Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology",
abstract = "Many events, including the COVID-19 pandemic, have accelerated the implementation of teledermatology pathways within dermatology departments and across healthcare organizations. Quality of Life (QoL) assessment in dermatology is also a rapidly developing field with a gradual shift from theory to practice. The purpose of this paper organized jointly by the European Academy of Dermatology and Venereology (EADV) Task Force (TF) on QoL and patient-oriented outcomes and the EADV TF on teledermatology is to present current knowledge about QoL assessment during the use of teledermatology approaches, including data on health-related (HR) QoL instruments used in teledermatology, comparison of influence of different treatment methods on HRQoL after face-to-face and teledermatology consultations and to make practical recommendations concerning the assessment of QoL in teledermatology. The EADV TFs made the following position statements: HRQoL assessment may be an important part in most of teledermatology activities; HRQoL assessment may be easily and effectively performed during teledermatology consultations. It is especially important to monitor HRQoL of patients with chronic skin diseases during lockdowns or in areas where it is difficult to reach a hospital for face-to-face consultation; regular assessment of HRQoL of patients with skin diseases during teledermatology consultations may help to monitor therapy efficacy and visualize individual patient's needs; we recommend the use of the DLQI in teledermatology, including the use of the DLQI app which is available in seven languages; it is important to develop apps for dermatology-specific HRQoL instruments for use in children (for example the CDLQI and InToDermQoL) and for disease-specific instruments.",
author = "Chernyshov, {P V} and Finlay, {A Y} and L Tomas-Aragones and L Tognetti and E Moscarella and P Pasquali and L Manolache and N Pustisek and A Svensson and Marron, {S E} and A Bewley and C Salavastru and A Suru and D Koumaki and D Linder and D Abeni and M Augustin and C Blome and Salek, {S S} and Evers, {A W M} and F Poot and F Sampogna and Szepietowski, {J С}",
note = "{\textcopyright} 2023 European Academy of Dermatology and Venereology.",
year = "2024",
month = feb,
doi = "10.1111/jdv.19570",
language = "English",
volume = "38",
pages = "254--264",
journal = "J EUR ACAD DERMATOL",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology

AU - Chernyshov, P V

AU - Finlay, A Y

AU - Tomas-Aragones, L

AU - Tognetti, L

AU - Moscarella, E

AU - Pasquali, P

AU - Manolache, L

AU - Pustisek, N

AU - Svensson, A

AU - Marron, S E

AU - Bewley, A

AU - Salavastru, C

AU - Suru, A

AU - Koumaki, D

AU - Linder, D

AU - Abeni, D

AU - Augustin, M

AU - Blome, C

AU - Salek, S S

AU - Evers, A W M

AU - Poot, F

AU - Sampogna, F

AU - Szepietowski, J С

N1 - © 2023 European Academy of Dermatology and Venereology.

PY - 2024/2

Y1 - 2024/2

N2 - Many events, including the COVID-19 pandemic, have accelerated the implementation of teledermatology pathways within dermatology departments and across healthcare organizations. Quality of Life (QoL) assessment in dermatology is also a rapidly developing field with a gradual shift from theory to practice. The purpose of this paper organized jointly by the European Academy of Dermatology and Venereology (EADV) Task Force (TF) on QoL and patient-oriented outcomes and the EADV TF on teledermatology is to present current knowledge about QoL assessment during the use of teledermatology approaches, including data on health-related (HR) QoL instruments used in teledermatology, comparison of influence of different treatment methods on HRQoL after face-to-face and teledermatology consultations and to make practical recommendations concerning the assessment of QoL in teledermatology. The EADV TFs made the following position statements: HRQoL assessment may be an important part in most of teledermatology activities; HRQoL assessment may be easily and effectively performed during teledermatology consultations. It is especially important to monitor HRQoL of patients with chronic skin diseases during lockdowns or in areas where it is difficult to reach a hospital for face-to-face consultation; regular assessment of HRQoL of patients with skin diseases during teledermatology consultations may help to monitor therapy efficacy and visualize individual patient's needs; we recommend the use of the DLQI in teledermatology, including the use of the DLQI app which is available in seven languages; it is important to develop apps for dermatology-specific HRQoL instruments for use in children (for example the CDLQI and InToDermQoL) and for disease-specific instruments.

AB - Many events, including the COVID-19 pandemic, have accelerated the implementation of teledermatology pathways within dermatology departments and across healthcare organizations. Quality of Life (QoL) assessment in dermatology is also a rapidly developing field with a gradual shift from theory to practice. The purpose of this paper organized jointly by the European Academy of Dermatology and Venereology (EADV) Task Force (TF) on QoL and patient-oriented outcomes and the EADV TF on teledermatology is to present current knowledge about QoL assessment during the use of teledermatology approaches, including data on health-related (HR) QoL instruments used in teledermatology, comparison of influence of different treatment methods on HRQoL after face-to-face and teledermatology consultations and to make practical recommendations concerning the assessment of QoL in teledermatology. The EADV TFs made the following position statements: HRQoL assessment may be an important part in most of teledermatology activities; HRQoL assessment may be easily and effectively performed during teledermatology consultations. It is especially important to monitor HRQoL of patients with chronic skin diseases during lockdowns or in areas where it is difficult to reach a hospital for face-to-face consultation; regular assessment of HRQoL of patients with skin diseases during teledermatology consultations may help to monitor therapy efficacy and visualize individual patient's needs; we recommend the use of the DLQI in teledermatology, including the use of the DLQI app which is available in seven languages; it is important to develop apps for dermatology-specific HRQoL instruments for use in children (for example the CDLQI and InToDermQoL) and for disease-specific instruments.

U2 - 10.1111/jdv.19570

DO - 10.1111/jdv.19570

M3 - SCORING: Journal article

C2 - 37877648

VL - 38

SP - 254

EP - 264

JO - J EUR ACAD DERMATOL

JF - J EUR ACAD DERMATOL

SN - 0926-9959

IS - 2

ER -